However, in another study [80] reduction in putaminal dopamine D2 receptor binding was weakly correlated with the probability of symptomatic conversion within 5 years, as calculated using a model based on age and CAG repeats, and the rate of change of putaminal D2 receptor binding was not increased around the time of HD symptom onset [80]. The gene discussed is DRD2; the disease is Huntington disease.